Predicted to enable fatty acid elongase activity. Predicted to be involved in fatty acid biosynthetic process; positive regulation of cold-induced thermogenesis; and sphingolipid biosynthetic process. Predicted to be located in endoplasmic reticulum. Predicted to be active in endoplasmic reticulum membrane. Orthologous to human ELOVL3 (ELOVL fatty acid elongase 3); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; alpha-Zearalanol.
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3; elongation of very long chain fatty acids protein 3; elongation of very long chain fatty acids-like 3; LOC309449; very long chain fatty acid elongase 3
[tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA
[Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA more ...
Dactinomycin inhibits the reaction [Norepinephrine results in increased expression of ELOVL3 mRNA] and Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA]
[Dietary Fats co-treated with Choline deficiency] results in decreased expression of ELOVL3 mRNA and PANX1 gene mutant form promotes the reaction [[Dietary Fats co-treated with Choline deficiency] results in decreased expression of ELOVL3 mRNA]
[Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA]
[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ELOVL3 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELOVL3 mRNA
PRKAA1 gene mutant form inhibits the reaction [Resveratrol results in increased expression of ELOVL3 mRNA] and Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ELOVL3 mRNA]
[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA